{
    "medicine_id": "20b7f0fe51d4279c23c79229ae977adf8b325669",
    "platform_id": "DB15568",
    "metadata": {
        "name": "Ak Tate Oph Sus 1 2 mg Suspension drops",
        "composition": "2 mg MRTX849",
        "clinical_particulars": {
            "therapeutic_indications": "MRTX849 is an experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant lung and colon adenocarcinomas A187559",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}